Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07161635 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 4 more changesShow less
    • Primary and study completion dates changed from estimate of Oct 2026 to Oct 8, 2026
    • Interventions: Clareon PanOptix Pro/Pro Toric Trifocal IOL (Device), Phacoemulsification (Procedure) to Clareon PanOptix Pro/Pro Toric Trifocal IOL (Device), Phacoemulsification (Procedure)
    • Eligibility criteria expanded, about 8 words
    • Site details revised at 1 of 5 sites
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 120 to confirmed 110
    • Site details revised at 5 of 5 sites
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2025 to Oct 14, 2025
    • Site details revised at 5 of 5 sites
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Alcon Research
30 trials monitored
See 3 trials at risk
The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.
Trial Details
NCT Number NCT07161635
Lead Sponsor Alcon Research
Conditions
(from sponsor)		 Aphakia, Presbyopia
Related terms Aphakia, Cataract, Presbyopia
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov